pain drug

	Status	1998-01-01 sales existent

Record changed: 2023-12-02

Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x200px

More documents for analgesic / antirheumatic

[1] Orexo AB. (12/22/25). "Press Release: Orexo Enters into Agreement with Dexcel Pharma USA to Divest US Rights to Zubsolv". Uppsala....
[2] SiteOne Therapeutics, Inc.. (2/4/25). "Press Release: SiteOne Therapeutics Announces Positive Phase 1 Clinical Data for STC-004, a Novel NaV1.8 Inhibitor in Development for the Non-Opioid Treatment of Pain". South San Francisco, CA....
[3] SiteOne Therapeutics, Inc.. (12/18/24). "Press Release: SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Pain". South San Francisco, CA....
[4] Cyxone AB. (5/20/20). "Press Release: Dr Tara Heitner Appointed New CEO for Cyxone"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)